To assess the medication adherence and symptom severity after nurse led psycho education.

Not yet recruiting

Conditions: Major depressive disorder, singleepisode, in full remission,

Registration Number: CTRI/2023/05/052309

Lead Sponsor: AIIMSNEW DELHI

Brief Summary: Depression is one of the most common mental disorders with more than 300 million people across all ages affected globally (WHO, 2018)

According to WHO, depression is the leading cause of disease burden globally, and it is on the rise (WHO, 2018). According to the National Mental Health Survey (NIMHANS report, 2016), overall weighted prevalence of depressive disorders was 2.7%for current experience and 5.3% for lifetime experience. According to a report in the year 2022, the prevalence rate of depression in India is 4.50% and the cases stand at 56,675,969.

Medication adherence is a common issue influenced by various factors among patients with depression worldwide. Depressive patients have more chances to change the medication, to change the dosage or to stop medication suddenly which can lead to severity of symptoms. To maintain treatment effectiveness and to reduce the severity of symptoms, it is important for patients with depressive disorder to keep taking their medications continuously over the long term.

Psychoeducational intervention has proved to be effective in reducing depression symptoms. It enhances the knowledge about illness, importance of medication adherence and general strategies to decrease the severity of symptoms. So there is a need of psycho education for depressive patients on regular basis.

So a nurse led psychoeducation can make a significant impact to improve medication adherence and reducing the symptom severity among patients with depression. This study will develop an evidence in effectiveness of nurse led psychoeducation program among depression patients.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 50

Inclusion Criteria

1 Patients who are willing to participate in the study, including willingness/ability to follow up after around a month.
2 Patients with the age group of 18-65 who have a diagnosis of depression (as per ICD-10 F 32 and F 33)- currently depressed (as per HAM-D and CUDOS) 3 Patients who have been on prescribed medications for at least one month or more, before recruiting into the study.

Exclusion Criteria

1Patients with co-occurring psychiatric disorders.
2Patients who are not able to read Hindi/English, unconscious and with severe depression.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the medication adherence after psychoeducation using medication adherence rating scale	4 WEEKS

Secondary Outcome Measures

Name	Time	Method
To assess the severity of symptoms after psychoeducation using HAM-D and CUDOS.	4 weeks

Trial Locations

Locations (1): All India institute of medical sciences
🇮🇳
Delhi, DELHI, India
All India institute of medical sciences
🇮🇳Delhi, DELHI, India
ANYSHA N
Principal investigator
9818362679
anyshan720@gmail.com